Advanced search
Publication Cover
Clinical Ophthalmology Volume 12, 2018 - Issue
Submit an article Journal homepage
58
Views
3
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Combination of ranibizumab and indomethacin for neovascular age-related macular degeneration: randomized controlled trial

Andrea Russo1 Eye Clinic, Department of Neurological and Vision Sciences, University of Brescia, BresciaCorrespondence[email protected]
,
Nicolò Scaroni1 Eye Clinic, Department of Neurological and Vision Sciences, University of Brescia, Brescia
,
Elena Gambicorti1 Eye Clinic, Department of Neurological and Vision Sciences, University of Brescia, Brescia
,
Raffaele Turano1 Eye Clinic, Department of Neurological and Vision Sciences, University of Brescia, Brescia
,
Francesco Morescalchi1 Eye Clinic, Department of Neurological and Vision Sciences, University of Brescia, Brescia
,
Ciro Costagliola2 Eye Clinic, Department of Health Sciences, University of Molise, Campobasso, Italy
&
Francesco Semeraro1 Eye Clinic, Department of Neurological and Vision Sciences, University of Brescia, Brescia
 show all
Pages 587-591 | Published online: 27 Mar 2018

References

  • KleinRKleinBEKKnudtsonMDPrevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosisOphthalmology2006113337338016513455
  • D’AmicoDJDiseases of the retinaN Engl J Med19943312951068208273
  • RosenfeldPJBrownDMHeierJSRanibizumab for neovascular age-related macular degenerationN Engl J Med2006355141419143117021318
  • HeierJSBrownDMChongVIntravitreal aflibercept (VEGF trap-eye) in wet age-related macular degenerationOphthalmology2012119122537254823084240
  • NitaMGrzybowskiAAscasoFJHuervaVAge-related macular degeneration in the aspect of chronic low-grade inflammation (pathophysiological parainflammation)Mediators Inflamm2014201493067125214719
  • LinTWalkerGBKurjiKParainflammation associated with advanced glycation endproduct stimulation of RPE in vitro: implications for age-related degenerative diseases of the eyeCytokine201362336938123601964
  • SemeraroFRussoADelcassiLTreatment of exudative age-related macular degeneration with ranibizumab combined with ketorolac eyedrops or photodynamic therapyRetina20153581547155425784358
  • RussoACostagliolaCDelcassiLRomanoMRSemeraroFA randomised controlled trial of ranibizumab with and without ketorolac eyedrops for exudative age-related macular degenerationBr J Ophthalmol201397101273127623873901
  • GomiFSawaMTsujikawaMNishidaKTopical bromfenac as an adjunctive treatment with intravitreal ranibizumab for exudative age-related macular degenerationRetina20123291804181022718152
  • RussoAMorescalchiFVezzoliSReduction of vitreous prostaglandin E2 levels after topical administration of indomethacin 0.5%, bromfenac 0.09%, and nepafenac 0.1Retina Phila Pa201636612271231
  • KimSJTomaHSInhibition of choroidal neovascularization by intravitreal ketorolacArch Ophthalmol2010128559620457981
  • SchoenbergerSDKimSJNonsteroidal anti-inflammatory drugs for retinal diseaseInt J Inflamm2013201318
  • FlaxelCSchainMBHamonSCFrancisPJProspective randomized controlled trial of combination ranibizumab (Lucentis) and bromfenac (Xibrom) for neovascular age-related macular degeneration: a pilot studyRetina201232341742321862953
  • SchoenbergerSDKimSJShengJCalcuttMWReduction of vitreous prostaglandin E2 levels after topical administration of ketorolac 0.45%JAMA Ophthalmol2014132215015424264034
  • SchoenbergerSDKimSJShahRShengJCherneyEReduction of interleukin 8 and platelet-derived growth factor levels by topical ketorolac, 0.45%, in patients with diabetic retinopathyJAMA Ophthalmol20141321323724336915
  • ChenEBenzMSFishRHUse of nepafenac (Nevanac) in combination with intravitreal anti-VEGF agents in the treatment of recalcitrant exudative macular degeneration requiring monthly injectionsClin Ophthalmol201041249125221151329
  • ErieJCBarkmeierAJHodgeDOMahrMAHigh variation of intravitreal injection rates and medicare anti-vascular endothelial growth factor payments per injection in the United StatesOphthalmology201612361257126226976701
  • RofaghaSBhisitkulRBBoyerDSSaddaSRZhangKSEVEN-UP Study GroupSeven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP)Ophthalmology2013120112292229923642856

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.